Abstract
In spite of optimal treatment of LDL - cholesterol, as per evidence -based guidelines, only a one third reduction in cardiovascular risk is achieved in our patients. This has led to the realization that other types of cholesterol, too, need to be treated, in order to achieve ideal cardiovascular health. The review focuses on high density lipoprotein (HDL) cholesterol as a target for treatment, its importance, relevant patents and current as well as future treatments.
Keywords: HDL cholesterol, hyperlipidemia, niacin, fibrates, statins
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title: HDL - Cholesterol: The New Target for Treatment
Volume: 4 Issue: 2
Author(s): Sanjay Kalra, Bharti Kalra, Navneet Agrawal and Ashraf Ganie
Affiliation:
Keywords: HDL cholesterol, hyperlipidemia, niacin, fibrates, statins
Abstract: In spite of optimal treatment of LDL - cholesterol, as per evidence -based guidelines, only a one third reduction in cardiovascular risk is achieved in our patients. This has led to the realization that other types of cholesterol, too, need to be treated, in order to achieve ideal cardiovascular health. The review focuses on high density lipoprotein (HDL) cholesterol as a target for treatment, its importance, relevant patents and current as well as future treatments.
Export Options
About this article
Cite this article as:
Kalra Sanjay, Kalra Bharti, Agrawal Navneet and Ganie Ashraf, HDL - Cholesterol: The New Target for Treatment, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2010; 4 (2) . https://dx.doi.org/10.2174/187221410791196605
DOI https://dx.doi.org/10.2174/187221410791196605 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Current Pharmaceutical Design Insights from Exercise-induced Cardioprotection-from Clinical Application to Basic Research
Current Pharmaceutical Design 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical and Pre-clinical Applications of the Transcendental Meditation Program® in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults
Current Hypertension Reviews Comprehensive Review of Cancer Chemopreventive Agents Evaluated in Experimental Carcinogenesis Models and Clinical Trials
Current Medicinal Chemistry Central Blood Pressure and Prediction of Cardiovascular Events
Current Hypertension Reviews Inflammatory Arthritis and Heart Disease
Current Pharmaceutical Design Importance of Dietary Supplements to the Health
Current Nutrition & Food Science Terminalia arjuna in Cardiovascular Diseases: Making the Transition from Traditional to Modern Medicine in India
Current Pharmaceutical Biotechnology Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis
Current Pharmaceutical Design Systemic Inflammation, Infection, ApoE Alleles, and Alzheimer Disease: A Position Paper
Current Alzheimer Research Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Is Hyperhomocyst(e)inemia A Humoral Predictor of Coronary Heart Disease?
Current Pharmaceutical Design The Use of Mesenchymal Stem Cells and their Derived Extracellular Vesicles in Cardiovascular Disease Treatment
Current Stem Cell Research & Therapy Cardiovascular Disease Risk and Hormone Replacement Therapy (HRT): A Review Based on Randomised, Controlled Studies in Postmenopausal Women
Current Medicinal Chemistry HCN Pacemaker Channels and Pain: A Drug Discovery Perspective
Current Pharmaceutical Design Bromodomain-Containing Protein 4: A Druggable Target
Current Drug Targets Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Mini-Reviews in Medicinal Chemistry The Role of Angiogenesis in Coronary Artery Disease: A Double-Edged Sword: Intraplaque Angiogenesis in Physiopathology and Therapeutic Angiogenesis for Treatment
Current Pharmaceutical Design Antioxidant Activity of Resveratrol Analogs
Letters in Drug Design & Discovery